NEWTON, Mass., May 12, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that initial data from a Phase 1 portion of the Ph 1/2 study evaluating selinexor in combination with…
News Ticker
- [ July 5, 2022 ] Senior Director CMC Regulatory – Enanta Pharmaceuticals – Watertown, MA Jobs
- [ July 5, 2022 ] Senior Principal Scientist – Bristol Myers Squibb – Cambridge, MA Jobs
- [ July 4, 2022 ] Senior Scientist – Astellas Pharmaceuticals – Westborough, MA Jobs
- [ July 4, 2022 ] Research Associate II – Astellas Pharmaceuticals – Westborough, MA Jobs
- [ July 4, 2022 ] Scientist I – Astellas Pharmaceuticals – Westborough, MA Jobs
Copyright © 2022 Biotech Networks, LLC
